Algert Global’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.6M Sell
308,980
-13,770
-4% -$148K 0.05% 560
2026
Q1
$2.73M Buy
322,750
+29,480
+10% +$323K 0.04% 624
2025
Q4
$3.31M Buy
293,270
+156,980
+115% +$1.94M 0.05% 574
2025
Q3
$2.05M Buy
136,290
+20,750
+18% +$302K 0.03% 682
2025
Q2
$1.63M Buy
115,540
+105,600
+1,062% +$1.88M 0.03% 691
2025
Q1
$239K Sell
9,940
-21,380
-68% -$754K 0.01% 1052
2024
Q4
$1.17M Sell
31,320
-1,072
-3% -$50K 0.03% 746
2024
Q3
$1.62M Buy
32,392
+24,990
+338% +$972K 0.04% 625
2024
Q2
$257K Buy
7,402
+412
+6% +$16.3K 0.01% 1181
2024
Q1
$382K Buy
+6,990
New +$346K 0.02% 833

Other funds holding BHVN

Algert Global's BHVN Position: Q2 2026 in Review

Algert Global reduced its Biohaven (BHVN) stake by 4.3% in Q2 2026, selling an estimated $148K and leaving 308,980 shares worth $4.6M. The position accounts for 0.05% of the portfolio, ranked #560.

Algert Global first reported a position in BHVN in Q1 2024 and has held it in 10 quarters since. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Algert Global held 308,980 shares of Biohaven worth $4.6M as of Q2 2026.
  • Algert Global sold 13,770 Biohaven shares in Q2 2026, an estimated $148K.
  • Biohaven made up 0.05% of Algert Global's portfolio in Q2 2026, its #560 holding.
  • Algert Global first reported a position in Biohaven in Q1 2024 and has held it in 10 quarters since.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.